Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Hongjitang Pharmaceutical Group is a historic Chinese pharmaceutical company founded in 1907, recognized as one of the most prestigious "Time-honored Brands" in Traditional Chinese Medicine (TCM). The company specializes in the research, development, and large-scale manufacturing of a diverse portfolio including Ejiao (donkey-hide gelatin), artificial musk, and various proprietary Chinese medicines in liquid, granule, and pill forms. Hongjitang integrates traditional healing heritage with modern pharmaceutical technology, operating advanced GMP-certified facilities to produce treatments for respiratory, cardiovascular, and pediatric health. As a core subsidiary of the Linuo Group, it maintains a significant market presence in China and exports products globally, positioning itself as a leader in the modernization of TCM.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hongjitang Pharmaceutical.